chr13-34942906-GCGGGGGCAGCGGTGGTGGCGGCAC-G
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2
The NM_001385012.1(NBEA):c.99_122delTGGTGGCGGCACCGGGGGCAGCGG(p.Gly34_Gly41del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000089 in 1,483,832 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000086 ( 0 hom. )
Consequence
NBEA
NM_001385012.1 disruptive_inframe_deletion
NM_001385012.1 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.40
Genes affected
NBEA (HGNC:7648): (neurobeachin) This gene encodes a member of a large, diverse group of A-kinase anchor proteins that target the activity of protein kinase A to specific subcellular sites by binding to its type II regulatory subunits. Brain-specific expression and coat protein-like membrane recruitment of a highly similar protein in mouse suggest an involvement in neuronal post-Golgi membrane traffic. Mutations in this gene may be associated with a form of autism. This gene and its expression are frequently disrupted in patients with multiple myeloma. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants may exist, but their full-length nature has not been determined.[provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_001385012.1
BP6
Variant 13-34942906-GCGGGGGCAGCGGTGGTGGCGGCAC-G is Benign according to our data. Variant chr13-34942906-GCGGGGGCAGCGGTGGTGGCGGCAC-G is described in ClinVar as [Likely_benign]. Clinvar id is 2643738.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000112 (17/151558) while in subpopulation EAS AF= 0.000199 (1/5018). AF 95% confidence interval is 0.0000795. There are 0 homozygotes in gnomad4. There are 10 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBEA | NM_001385012.1 | c.99_122delTGGTGGCGGCACCGGGGGCAGCGG | p.Gly34_Gly41del | disruptive_inframe_deletion | 1/59 | ENST00000379939.7 | NP_001371941.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151450Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
17
AN:
151450
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000152 AC: 16AN: 105454Hom.: 0 AF XY: 0.000209 AC XY: 12AN XY: 57286
GnomAD3 exomes
AF:
AC:
16
AN:
105454
Hom.:
AF XY:
AC XY:
12
AN XY:
57286
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000863 AC: 115AN: 1332274Hom.: 0 AF XY: 0.000103 AC XY: 67AN XY: 652938
GnomAD4 exome
AF:
AC:
115
AN:
1332274
Hom.:
AF XY:
AC XY:
67
AN XY:
652938
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 151558Hom.: 0 Cov.: 30 AF XY: 0.000135 AC XY: 10AN XY: 74082
GnomAD4 genome
AF:
AC:
17
AN:
151558
Hom.:
Cov.:
30
AF XY:
AC XY:
10
AN XY:
74082
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
1
AN:
3458
ClinVar
Significance: Likely benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
NBEA-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 02, 2024 | The NBEA c.99_122del24 variant is predicted to result in an in-frame deletion (p.Gly34_Gly41del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | NBEA: BS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at